Welcome to our dedicated page for Ellomay Cap SEC filings (Ticker: ELLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ellomay Capital Ltd. filings document a foreign private issuer focused on renewable energy and power generation and development in Europe, the United States and Israel. Its Form 20-F and Form 6-K reports disclose operating and financial results, project development costs, portfolio holdings, and securities listed on the NYSE American and the Tel Aviv Stock Exchange.
The company’s regulatory record also covers material-event disclosures tied to asset sales, Ellomay Luzon Energy Infrastructures Ltd., Dorad Energy Ltd., and capital-structure matters involving Series E Secured Debentures, collateral and repayment notices. Governance filings include principal shareholder changes, board composition updates, registration-statement incorporation by reference, and risk-related forward-looking statement disclosures.
Ellomay Capital Ltd. (ELLO) reports a key milestone in its plan to enlarge its position in Dorad Energy Ltd. On 10 July 2025 Dorad’s board approved the transfer of 7.5 % of Dorad’s outstanding shares to Ellomay’s wholly owned subsidiary, Ellomay Luzon Energy Infrastructures Ltd., and a separate transfer of 10 % to The Phoenix Insurance Company Ltd. The approval formally validates Ellomay’s previously exercised right of first refusal.
- The sole remaining closing condition for Ellomay’s initial 7.5 % purchase is the consummation of Phoenix’s 10 % acquisition, a step that is outside Ellomay’s control.
- Ellomay has reserved the right to acquire an additional 7.5 % should a parallel purchase by Edelcom Ltd. fail to close.
- No purchase price, financing structure or earnings impact was disclosed in the filing.
Management cannot currently estimate when—or if—the closing condition will be satisfied. The filing reiterates extensive forward-looking-statement caveats concerning regulatory approvals, market conditions, geopolitical risks and other uncertainties in Israel, Spain, Italy and the U.S.